Literature DB >> 10727411

Intracellular maturation and localization of the tumour necrosis factor alpha convertase (TACE).

J Schlöndorff1, J D Becherer, C P Blobel.   

Abstract

Tumour necrosis factor alpha convertase (TACE) is a metalloprotease/disintegrin involved in the ectodomain shedding of several proteins, a process thought to be important in inflammation, rheumatoid arthritis and murine development. The characterization of the intracellular maturation and subcellular localization of endogenous TACE is decribed in the present study. Similarly to other proteolytically active metalloprotease/disintegrins, two forms of TACE are found in cells; a full-length precursor and a mature form lacking the prodomain. Prodomain removal occurs in a late Golgi compartment, consistent with the proposed role of a furin type proprotein convertase in this process. An additional form of TACE, lacking the pro and cytoplasmic domains, is detected when cell lysates are prepared in the presence of EDTA instead of a hydroxamate-based metalloprotease inhibitor or 1,10-phenanthroline. This form appears to be generated by mature TACE cleaving its own cytoplasmic tail and may explain why little mature TACE has been detected in previous studies. In cell-surface labelling experiments, mature TACE was detected on the cell surface but immunofluorescence data indicate that TACE is predominantly localized to a perinuclear compartment similar to that described for tumour necrosis factor (TNF)alpha. This raises the possibility that TACE-mediated ectodomain shedding may occur in an intracellular compartment in addition to the cell surface.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10727411      PMCID: PMC1220940     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  26 in total

Review 1.  The ADAM gene family: surface proteins with adhesion and protease activity.

Authors:  P Primakoff; D G Myles
Journal:  Trends Genet       Date:  2000-02       Impact factor: 11.639

2.  Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha.

Authors:  M L Moss; S L Jin; M E Milla; D M Bickett; W Burkhart; H L Carter; W J Chen; W C Clay; J R Didsbury; D Hassler; C R Hoffman; T A Kost; M H Lambert; M A Leesnitzer; P McCauley; G McGeehan; J Mitchell; M Moyer; G Pahel; W Rocque; L K Overton; F Schoenen; T Seaton; J L Su; J D Becherer
Journal:  Nature       Date:  1997-02-20       Impact factor: 49.962

3.  A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells.

Authors:  R A Black; C T Rauch; C J Kozlosky; J J Peschon; J L Slack; M F Wolfson; B J Castner; K L Stocking; P Reddy; S Srinivasan; N Nelson; N Boiani; K A Schooley; M Gerhart; R Davis; J N Fitzner; R S Johnson; R J Paxton; C J March; D P Cerretti
Journal:  Nature       Date:  1997-02-20       Impact factor: 49.962

4.  Metargidin, a membrane-anchored metalloprotease-disintegrin protein with an RGD integrin binding sequence.

Authors:  J Krätzschmar; L Lum; C P Blobel
Journal:  J Biol Chem       Date:  1996-03-01       Impact factor: 5.157

5.  Evidence for an interaction of the metalloprotease-disintegrin tumour necrosis factor alpha convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease-disintegrin MDC9 with a novel MAD2-related protein, MAD2beta.

Authors:  K K Nelson; J Schlöndorff; C P Blobel
Journal:  Biochem J       Date:  1999-11-01       Impact factor: 3.857

6.  The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family.

Authors:  H E Van Wart; H Birkedal-Hansen
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

7.  Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors.

Authors:  J Arribas; L Coodly; P Vollmer; T K Kishimoto; S Rose-John; J Massagué
Journal:  J Biol Chem       Date:  1996-05-10       Impact factor: 5.157

8.  Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor.

Authors:  G M McGeehan; J D Becherer; R C Bast; C M Boyer; B Champion; K M Connolly; J G Conway; P Furdon; S Karp; S Kidao
Journal:  Nature       Date:  1994-08-18       Impact factor: 49.962

9.  Rapid plasma membrane anchoring of newly synthesized p59fyn: selective requirement for NH2-terminal myristoylation and palmitoylation at cysteine-3.

Authors:  W van't Hof; M D Resh
Journal:  J Cell Biol       Date:  1997-03-10       Impact factor: 10.539

10.  Transforming growth factor-alpha and beta-amyloid precursor protein share a secretory mechanism.

Authors:  J Arribas; J Massagué
Journal:  J Cell Biol       Date:  1995-02       Impact factor: 10.539

View more
  114 in total

1.  Cloning and characterization of ADAM28: evidence for autocatalytic pro-domain removal and for cell surface localization of mature ADAM28.

Authors:  L Howard; R A Maciewicz; C P Blobel
Journal:  Biochem J       Date:  2000-05-15       Impact factor: 3.857

Review 2.  Small therapeutic molecules for the treatment of inflammatory bowel disease.

Authors:  S J H van Deventer
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

Review 3.  Mucins and blastocyst attachment.

Authors:  Amantha Thathiah; Daniel D Carson
Journal:  Rev Endocr Metab Disord       Date:  2002-05       Impact factor: 6.514

4.  Transmembrane collagen XVII, an epithelial adhesion protein, is shed from the cell surface by ADAMs.

Authors:  Claus-Werner Franzke; Kaisa Tasanen; Heike Schäcke; Zhongjun Zhou; Karl Tryggvason; Cornelia Mauch; Paola Zigrino; Susan Sunnarborg; David C Lee; Falk Fahrenholz; Leena Bruckner-Tuderman
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

5.  Hypothalamic tumor necrosis factor-alpha converting enzyme mediates excitatory amino acid-dependent neuron-to-glia signaling in the neuroendocrine brain.

Authors:  Alejandro Lomniczi; Anda Cornea; Maria E Costa; Sergio R Ojeda
Journal:  J Neurosci       Date:  2006-01-04       Impact factor: 6.167

6.  IL-1beta augments TNF-alpha-mediated inflammatory responses from lung epithelial cells.

Authors:  Sara Saperstein; Linlin Chen; David Oakes; Gloria Pryhuber; Jacob Finkelstein
Journal:  J Interferon Cytokine Res       Date:  2009-05       Impact factor: 2.607

7.  The growth hormone receptor interacts with its sheddase, the tumour necrosis factor-alpha-converting enzyme (TACE).

Authors:  Julia A Schantl; Marcel Roza; Peter Van Kerkhof; Ger J Strous
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

8.  A Lactobacillus rhamnosus GG-derived soluble protein, p40, stimulates ligand release from intestinal epithelial cells to transactivate epidermal growth factor receptor.

Authors:  Fang Yan; Liping Liu; Peter J Dempsey; Yu-Hwai Tsai; Elaine W Raines; Carole L Wilson; Hailong Cao; Zheng Cao; LinShu Liu; D Brent Polk
Journal:  J Biol Chem       Date:  2013-09-16       Impact factor: 5.157

9.  Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx.

Authors:  Keisuke Horiuchi; Sylvain Le Gall; Marc Schulte; Takafumi Yamaguchi; Karina Reiss; Gillian Murphy; Yoshiaki Toyama; Dieter Hartmann; Paul Saftig; Carl P Blobel
Journal:  Mol Biol Cell       Date:  2006-11-01       Impact factor: 4.138

10.  ADAM17 stabilizes its interacting partner inactive Rhomboid 2 (iRhom2) but not inactive Rhomboid 1 (iRhom1).

Authors:  Gisela Weskamp; Johanna Tüshaus; Daniel Li; Regina Feederle; Thorsten Maretzky; Steven Swendemann; Erik Falck-Pedersen; David R McIlwain; Tak W Mak; Jane E Salmon; Stefan F Lichtenthaler; Carl P Blobel
Journal:  J Biol Chem       Date:  2020-02-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.